1. CapsoVision Targets FDA 510(k) for Next-Gen Colon Capsule & AI Module by Q3 2026
CapsoVision is advancing its next-generation colon capsule technology, targeting a critical FDA 510(k) submission for its Gen 2 Colon capsule and integrated AI module by the third quarter of 2026. This strategic regulatory milestone comes as the company reports accelerating commercial adoption of its current platform, ...